Adverse events reported in the context of the use of cannabis or cannabinoid derivatives: exploration of data recorded in Vigibase

被引：0
|
作者：
Jouanjus, Emilie [1 ,2 ]
Deguilhem, Amelia [3 ]
Merad, Sonia [1 ]
Lapeyre-Mestre, Maryse [1 ,2 ]
机构：
[1] CHU Toulouse, Serv Pharmacol Med & Clin, Ctr Evaluat & Informat Pharmacodependance CEIP, Allees Jules Guesde, F-31000 Toulouse, France
[2] Univ Toulouse III Paul Sabatier, Equipe Pharmacoepidemiol, INSERM, UMR 1027, Toulouse, France
[3] Univ Paris Sarclay, AP HP, Paris, France
来源：
THERAPIE | 2021年 / 76卷 / 02期
关键词：
D O I：
10.1016/j.therap.2021.01.048
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P35
引用
收藏
页码：180 / 181
页数：2
相关论文
共 50 条
  • [41] An Exploration of Self-Reported Medicinal Cannabis Use Among a Sample of Eastern Canadian Postsecondary Students
    Jacqueline Smith
    Jennifer Smith
    Joel Mader
    Gabrielle Guestier
    Lauren Conn
    Joy Maddigan
    The Journal of Behavioral Health Services & Research, 2022, 49 : 487 - 499
  • [42] Suspected cutaneous adverse drug reactions reported with traditional medicines: analysis of data for United Nations Asia region from WHO VigiBase
    Barvaliya, Manish J. J.
    Chetan, A. C.
    Chandan, N.
    Ray, Suman Kumar
    Hegde, Harsha V. V.
    Unger, Banappa S. S.
    Patel, Tejas K. K.
    Roy, Subarna
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [43] Hospitalizations for cardiovascular reasons of young consumers of cannabis identified from the exploration of the data of PMSI recorded at Toulouse University hospital
    Jouanjus, Emilie
    Monpagens, Claire
    Petiot, Dominique
    Molinier, Laurent
    Lapeyre-Mestre, Maryse
    THERAPIE, 2017, 72 (01): : 159 - 160
  • [44] Impact of Concomitant Tobacco Use on Major Adverse Cardiovascular Events in Young Adults Hospitalized With Known Cannabis Use Disorder
    Yarrarapu, Siva Naga S.
    Abrishami, Shabnam
    Narula, Harshit
    Singh, Monika
    Mahadevaiah, Ashwini
    Niaz, Rabiya
    Aqeel, Mariam
    Saeed, Memoona
    Thota, Anjani Kumar
    Desai, Rupak
    CIRCULATION, 2022, 146
  • [45] Does cannabis testing in the military drive synthetic cannabinoid use? Self-reported use motivations among justice-involved veterans
    Santangelo, Orion
    Baldwin, Julie Marie
    Stogner, John
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2022, 106
  • [46] Cannabis use in people with Parkinson's disease: Reported patterns of use, symptomatic benefits, and adverse effects via Fox Insight
    Holden, Samantha
    Domen, Christopher
    Sillau, Stefan
    Liu, Ying
    Leehey, Maureen
    NEUROLOGY, 2021, 96 (15)
  • [47] Potential Signals for Cardiovascular-Related Adverse Events with COX Inhibitor Use: Analysis of the WHO Global ICSR Database System (VigiBase)
    Prieto-Merino, David
    Kim, Joseph
    Evans, Stephen J. W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 446 - 447
  • [48] Comparison of Events in Spontaneous Adverse Event Reports to Events Discussed Within Context of Drug Use on Facebook and Twitter
    Powell, Gregory
    Bell, Heidi
    Rodriguez, Harold
    Thomas, Michele
    Painter, Jeffery
    Harvey, Cath
    Blowers, James
    Dasgupta, Nabarun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 441 - 441
  • [49] Incidence of cardiovascular symptoms and adverse events following self-reported acute cannabis intoxication at the emergency department: a retrospective study
    Gresnigt, Femke
    van den Brink, Lianne C.
    Hunault, Claudine
    Franssen, Eric
    de Lange, Dylan
    Riezebos, Robert
    EMERGENCY MEDICINE JOURNAL, 2023, 40 (05) : 357 - 358
  • [50] Adverse Developmental Events Reported to FDA in Association with Maternal Use of Drugs for Treatment of Hyperthyroidism in Pregnancy
    Tabacova, S.
    Szarfman, A.
    Lyndly, J. M.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2010, 88 (05) : 411 - 411
12345